Stay updated on Nemtabrutinib in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Nemtabrutinib in Hematologic Malignancies Clinical Trial page.

Latest updates to the Nemtabrutinib in Hematologic Malignancies Clinical Trial page
- Check5 days agoChange DetectedRevision metadata updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded: Revision v3.4.2; removed: the government funding/status notice and Revision v3.4.1.SummaryDifference0.3%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check48 days agoChange DetectedAdded a glossary display option and introduced QC-related metadata (Last Update Submitted that Met QC Criteria), No FEAR Act Data label, and Revision: v3.4.0. Removed the prior QC field wording (Last Update Submitted that met QC Criteria), No FEAR Act data label, and Revision: v3.3.4.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded a centralized Locations section with state listings for study sites (Arizona, California, Colorado, Michigan, Minnesota, North Carolina, Ohio, Tennessee, Texas, Utah) and removed the old per-location pages for these states. Updated the revision to v3.3.3.SummaryDifference0.9%

Stay in the know with updates to Nemtabrutinib in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nemtabrutinib in Hematologic Malignancies Clinical Trial page.